Pornography Abstinence and Nocturnal Erections in Adult Men

May 26, 2026 updated by: Efforia, Inc

A Real-World Observational Study Evaluating the Effects of 30 Days of Pornography Abstinence on Nocturnal Penile Tumescence, Sexual Function, and Well-Being in Adult Men

The effects of pornography use on male sexual health remain uncertain, with mixed findings across existing literature and substantial variability at the individual level. This observational study is designed to help participants evaluate how a 30-day period of pornography abstinence affects their own sexual health and well-being, with a specific focus on nocturnal penile tumescence as a physiological biomarker.

Participants will complete a short baseline observation period during which they maintain their usual pornography consumption patterns, followed by a 30-day abstinence period. Objective nocturnal erection data will be collected using a connected wearable device, alongside validated self-report questionnaires assessing erectile function, sexual desire, mood, energy, and emotional well-being. Participants serve as their own control, allowing for within-person comparisons of outcomes before and during the abstinence period.

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

This single-arm, real-world observational study evaluates the association between pornography abstinence and changes in nocturnal penile tumescence, sexual function, and psychosocial outcomes in adult men.

During an initial baseline phase, participants continue their typical pornography use while collecting objective nocturnal erection data and completing baseline questionnaires. Participants then enter a 30-day abstinence period, during which they attempt to refrain from pornography use. Abstinence adherence is self-reported, with lapses logged as observational data rather than protocol violations.

Nocturnal penile tumescence is assessed nightly using the Adam Sensor, a non-invasive wearable device that measures changes in penile circumference during sleep. Additional outcomes are assessed using validated questionnaires administered at baseline and at weekly intervals. The study is exploratory and signal-detecting in nature and is not designed to establish causality.

Study Design

Study Type: Observational

Study Design: Single-arm, within-participant comparison

Time Perspective: Prospective

Masking: None (Open Label)

Primary Purpose: Health outcomes assessment / signal detection

Additional information can be found at the study recruitment landing page here: https://app.efforia.com/30-day-tv-abstinence-challenge/

Study Type

Observational

Enrollment (Estimated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • New York
      • New York, New York, United States, 10003
        • Recruiting
        • Efforia
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Adult men who are interested in evaluating how a 30-day period of pornography abstinence may affect their sexual health, nocturnal erections, and overall well-being. Participants are self-selected volunteers who report current or recent pornography use, are able to attempt abstinence for the duration of the study, and are willing to use a non-invasive wearable device to collect nocturnal penile tumescence data and complete electronic questionnaires. The study population reflects a real-world, consumer-based sample rather than a clinically diagnosed population.

Description

Inclusion Criteria:

  • Adult males of legal age of consent
  • Willingness to attempt pornography abstinence
  • Ability to use a wearable device during sleep
  • Ability to complete electronic surveys
  • Willingness to purchase the study device

Exclusion Criteria:

  • Have a history of significant sexual dysfunction requiring active medical treatment
  • Have current or uncontrolled mental health disorders
  • Have a history of addictive behaviors that may be exacerbated by abstinence
  • Are undergoing hormonal therapy or treatment affecting sexual function
  • Are experiencing unstable interpersonal or relationship stressors
  • Have significant concerns about privacy related to sexual health data
  • Have cultural or religious considerations that could cause distress

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Single Arm longitudinal where participants act as their own control
Participants will attempt to abstain from all pornography use for 30 consecutive days. Any deviations from abstinence are self-reported and logged for contextual analysis.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Nocturnal Penile Tumescence
Time Frame: Baseline Day to Day 38

Measure: Adam Sensor - Nocturnal Erection Tracking

Description:

Objective measurement of nocturnal penile tumescence, Frequency/Time nocturnal erections per night

Baseline Day to Day 38

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Erectile Function
Time Frame: Baseline to Day 38 after intervention

Measure: International Index of Erectile Function (IIEF-15)

Scale Range: 5-75 (higher scores indicate better erectile and sexual function)

Description:

Assesses erectile function, orgasmic function, sexual desire, intercourse satisfaction, and overall satisfaction.

Baseline to Day 38 after intervention
Change in Sexual Desire
Time Frame: Baseline to Day 38 after intervention

Measure: Sexual Desire Inventory-2 (SDI-2)

Scale Range: 0-112 (higher scores indicate greater sexual desire)

Description:

Measures both dyadic and solitary sexual desire.

Baseline to Day 38 after intervention
Change in Pornography Consumption Patterns
Time Frame: Baseline to Day 38 after intervention

Measure: Weekly Pornography Consumption Survey (custom self-report)

Scale: Frequency and duration categories (ordinal)

Description:

Tracks self-reported pornography use and abstinence adherence.

Baseline to Day 38 after intervention
Change in Mood, Energy, and Emotional Well-Being
Time Frame: Baseline to Day 38 after intervention

Measure: Weekly Self-Assessment Check-In (custom)

Scale: 1-10 Likert-type scales (higher scores indicate more favorable states)

Description:

Assesses perceived mood, mental clarity, energy level, and emotional resilience.

Baseline to Day 38 after intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 22, 2025

Primary Completion (Estimated)

September 22, 2026

Study Completion (Estimated)

September 22, 2026

Study Registration Dates

First Submitted

February 24, 2026

First Submitted That Met QC Criteria

May 26, 2026

First Posted (Actual)

June 1, 2026

Study Record Updates

Last Update Posted (Actual)

June 1, 2026

Last Update Submitted That Met QC Criteria

May 26, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 38321

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Erection; Incomplete

Clinical Trials on Pornography Abstinence

Subscribe